M&A Deal Summary

BioLife Solutions Acquires Sexton Biotechnologies

On August 9, 2021, BioLife Solutions acquired life science company Sexton Biotechnologies

Acquisition Highlights
  • This is BioLife Solutions’ 2nd transaction in the Life Science sector.
  • This is BioLife Solutions’ 6th transaction in the United States.
  • This is BioLife Solutions’ 1st transaction in Indiana.

M&A Deal Summary

Date 2021-08-09
Target Sexton Biotechnologies
Sector Life Science
Buyer(s) BioLife Solutions
Deal Type Add-on Acquisition

Target

Sexton Biotechnologies

Indianapolis, Indiana, United States
Sexton Biotechnologies is a revenue-stage, biotechnology company focused on the development and sales of bioproduction tools for cell and gene therapy. Sexton develops purpose-built cell and gene therapy (CGT) tools and media to enable flexible automation and scaling of cell manufacturing processes to increase the probability of positive clinical outcomes and reduce time-to-market, failure points and labor costs. Sexton Biotechnologies Indianapolis is based in Indianapolis, Indiana.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

BioLife Solutions

Bothell, Washington, United States

Category Company
Founded 1987
Sector Life Science
Employees409
Revenue 143M USD (2023)
DESCRIPTION

BioLife Solutions is a developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. Our proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the regenerative medicine, biobanking and drug discovery markets. Our biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death; offering commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function. BioLife Solutions was founded in 1987 and is based in Bothell, Washington.


DEAL STATS #
Overall 6 of 6
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 5 of 5
State (Indiana) 1 of 1
Country (United States) 6 of 6
Year (2021) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-22 Stirling Ultracold

Athens, Ohio, United States

Stirling Ultracold is a manufacturer of ultra-low temperature ("ULT") mechanical freezers. Stirling Ultracold also produces the industry's only portable ULT solution available for remote clinical trials and biologic drug delivery. Stirling Ultracold was founded in 2009 and is based in Athens, Ohio.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-11-12 SciSafe

Cranbury, New Jersey, United States

SciSafe is a provider of biological materials storage to the cell and gene therapy and pharmaceutical industries. SciSafe was established in 2010 and is based in Cranbury, New Jersey.

Sell $73M